[18F]MK-6240

MK-6240 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [18F]MK-6240, covering 2018-07-23 to 2018-07-23. Get the full timeline:

Most recent: Clinical Trial Update: [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001) [Phase 1]